
Big Coffee Study Finds Daily Cups May Lower Liver Disease and Liver Cancer Risk
A UK Biobank analysis of about 355,000 adults over roughly 13 years links coffee intake to substantially lower risks of cirrhosis, liver-related death, and hepatocellular carcinoma, with stronger protection at higher consumption (one to two cups daily reduces cirrhosis by ~20% and liver mortality by ~31%; five or more cups reduces cirrhosis by ~32%, liver death by ~42%, and liver cancer by ~47%). Benefits were similar for caffeinated and decaf coffee and persisted with or without sugar, though added sugars may blunt some effects. Being observational and based on self-reported data, the study shows correlation rather than causation and coffee should complement—not replace—standard preventive health practices.













